● Investment fund Global Infrastructure Partners agreed to buy Equis Energy, a Singaporean developer of renewable energy projects, for record-breaking for the industry $5 billion, writes Bloomberg.
● Dow Jones hits record. Dow Jones industrial average rises sharply on Tuesday amid strong quarterly results from 3M and Caterpillar, reports CNBC.
● American private equity fund Cerberus Capital Management has expressed interest in buying Alitalia, financially troubled. Cerberus wants, for Alitalia to remain an independent airline. But earlier, EasyJet and Lufthansa have already made their proposals.
Gapping down
In reaction to disappointing earnings/guidance:
- ACHC -22.3%, AMD -10.7%, CMG -10.6%, POWERFUL -9.9%, GHM -8.5%, JNPR -6.7%, THAT ONE -6.3%, VICR -6.3%, DPS -5.1%, SFLY -3.6%, NBR -3.4%, EXP -3.3%, DFS -3.1%, WYN -2.3%, AMX -2.1%, T -2%, TXN -1.7%, OC -1.6%, ESRX -1.4%, ROLE -1.1%
Other news:
- SNSS -13.5% (commences offering of common stock and Series D Convertible Preferred Stock)
- SVRA -11% (commences common stock offering; size not disclosed; anounces its indication expansion strategy of its lead product candidate Molgradex for the treatment of nontuberculous mycobacterial lung infection; plans to initiate a Phase 2a multi-center clinical trial in subjects with antibiotic-resistant NTM lung infection in early 2018)
- Ho Chi Minh City -9.4% (to offer $262.0 million of ADS’s, each representing one-half of one ordinary share )
- IDRA -8.7% ( commences $60 mln common stock offering)
- SALT -7.8% (commences 10 mln common stock offering )
- BIOA -6.5% (accepted the resignation of Pres/COO Fabrice Orecchioni; will be assuming advisory role through to February 24, 2018)
- SACH -6% (prices 3.75 mln common stock offering at $4.00/share)
- PFLT -4.5% (to make a public offering of 6,000,000 shares of its common stock )
- ATNM -4.1% ( indicated lower after filing for $200 mln mixed securities shelf offering and $75 mln ATM under 424B3)
- IMDZ -1.1% (prices 18.5 mln shares of common stock at $4.10 per share)
- NVDA -0.5% (following AMD results)
Analyst comments:
- RCII -5.3% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- PII -1.7% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- GM -1.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- HBI -1% (downgraded to Market Perform from Outperform at Wells Fargo)
- NVS -0.5% (downgraded to Underweight from Equal Weight at Barclays)
Gapping up
In reaction to strong earnings/guidance:
- APOP +25.4%, CAPR +18.6%, MY BROTHER +8.5%, MDCO +8.1%, IRBT +5.6%, LIP +4.5%, WBA +4.4%, MKSI +4.3%, KRA +4.1%, LPL +4.1%, RES +3.5%, RGC +3.4%, BTI +3.1%, (provides update to outlook at its Capital Markets Day), TUP +3%, NIGHT +2.9%,TSS +2.7%, OFG +2.5%, FLIR +2.5%, AMED +2.4%, WB +2.3%, (also commences $700 mln offering of convertible senior notes due 2022 ), ILMN +2%, MEMORY +1.9%, LYG +1.7%, HES +1.7%, SIX +1.5%, VNOM +1.4%, BXMT +1.4%, SIRI +1.4%, AVY +1.1%,CNI +1%, NUVA +1%, CEO +0.8%, To +0.8%, BAX +0.6%
M&A news:
- S +1.4% (T-Mobile US and Sprint (S) are preparing Boards for merger decision, according to Reuters)
Other news:
- BRIDGE +21.2% (after closing near highs on credit facility update)
- OSTK +4.4% (extending today’s move higher after confirming key details on tZERO’s ICO at Money 20/20 )
- LL +4.4% (disclosed memorandum of understanding to settle class actions related to Chinese-Laminate flooring )
- Sens +3.3% (continued strength)
- ANTME +2.8% (announces that the Co has successfully activated fifteen clinical trial sites in the pivotal Phase 3 SIERRA trial for Iomab-B)
- MZOR +2.3% (reports 379-Patient controlled study also reveals seven-fold reduction in revision surgery)
- AMC +1.4% (following RGC results)
- TNDM +1.1% (to make any new features approved for the t:slim X2 Insulin Pump by the FDA in 2018 available to all in-warranty users at no cost through the Tandem Device Updater )
- VRAY +0.9% (raised approx $50 mln through offering)
Analyst comments:
- ALDX +4.8% (initiated with a Overweight at Cantor Fitzgerald)
- ILMN +2% (upgraded to Outperform at Robert W. Baird)
- LDOS +1.4% (upgraded to Outperform from Market Perform at Wells Fargo)
- UAL +1% (upgraded to Outperform at Evercore ISI)